Pharmacodynamics of glucose regulation by methylprednisolone. I. adrenalectomized rats

Biopharmaceutics and Drug Disposition

Volumn 30, Issue 1, 2009, Pages 21-34

  Jin, Jin Y ^a   Jusko, William J ^a  

^a UNIVERSITY AT BUFFALO   (United States)

Author keywords

Corticosteroids; Glucose; Insulin; Methylprednisolone; Pharmacodynamics; Pharmacokinetics

Indexed keywords

GLUCOSE; INSULIN; METHYLPREDNISOLONE SODIUM SUCCINATE;

ADRENALECTOMY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL STIMULATION; CONTINUOUS INFUSION; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE COURSE; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG HALF LIFE; DRUG MEGADOSE; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; HYPERGLYCEMIA; INSULIN BLOOD LEVEL; INSULIN RELEASE; LOW DRUG DOSE; MALE; NONHUMAN; PANCREAS ISLET BETA CELL; RAT; SINGLE DRUG DOSE;

ADRENALECTOMY; ALGORITHMS; ANIMALS; ANTI-INFLAMMATORY AGENTS; BLOOD GLUCOSE; BODY WEIGHT; DATA INTERPRETATION, STATISTICAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; GLUCOSE; HOMEOSTASIS; INFUSIONS, INTRAVENOUS; INJECTIONS, INTRAVENOUS; INSULIN; MALE; METHYLPREDNISOLONE; RATS; RATS, WISTAR;

EID: 59949103062     PISSN: 01422782     EISSN: 1099081X     Source Type: Journal    
DOI: 10.1002/bdd.643     Document Type: Article

References (39)

1. Wilcke JR, Davis LE. Review of glucocorticoid pharmacology. Vet Clin North Am Small Anim Pract 1982; 12: 3-17.
2. Baxter JD, Forsham PH. Tissue effects of glucocorticoids. Am J Med 1972; 53: 573-589.
3. Hirsch IB, Paauw DS. Diabetes management in special situations. Endocrinol Metab Clin North Am 1997; 26: 631-645.
4. Haughey DB, Jusko WJ. Analysis of methylprednisolone, methylprednisone and corticosterone for assessment of methylprednisolone disposition in the rat. J Chromatogr 1988; 430: 241-248.
5. Sun YN, DuBois DC, Almon RR, Jusko WJ. Fourth-generation model for corticosteroid pharmacodynamics: a model for methylprednisolone effects on receptor/gene-mediated glucocorticoid receptor down-regulation and tyrosine amino-transferase induction in rat liver. J Pharmacokinet Biopharm 1998; 26: 289-317.
6. Sun YN, DuBois DC, Almon RR, Pyszczynski NA, Jusko WJ. Dose-dependence and repeated-dose studies for receptor/gene-mediated pharmacodynamics of methylprednisolone on glucocorticoid receptor down- regulation and tyrosine aminotransferase induction in rat liver. J Pharmacokinet Biopharm 1998; 26: 619-648.
7. Ramakrishnan R, DuBois DC, Almon RR, Pyszczynski NA, Jusko WJ. Pharmacodynamics and pharmacogenomics of methylprednisolone during 7-day infusions in rats. J Pharmacol Exp Ther 2002; 300: 245-256.
8. Dayneka NL, Garg V, Jusko WJ. Comparison of four basic models of indirect pharmacodynamic responses. J Pharmacokinet Biopharm 1993; 21: 457-478.
9. Flakoll PJ, Carlson MG, Cherrington AD. Chapter 14. Physiologic action of insulin. in: LeRoith D, Taylor SI, Olefsky JM (Eds.), Diabetes Mellitus A Fundamental and Clinical Text, 2nd edn. Lippincott Williams & Wilkins: Philadelphia, 2000; 148-161.
10. D'Argenio DZ, Schumitzky A. ADAPT II User's Guide Pharmacokinetic/ Pharmacodynamic Systems Analysis Software. BioMedical Simulations Resource: Los Angeles, 1997.
11. Tranquilli WJ, Thurmon JC, Neff-Davis CA et al. Hyperglycemia and hypoinsulinemia during xylazine-ketamine anesthesia in thoroughbred horses. Am J Vet Res 1984; 45: 11-14.
12. Hindlycke M, Jansson L. Glucose tolerance and pancreatic islet blood flow in rats after intraperitoneal administration of different anesthetic drugs. Ups J Med Sci 1992; 97: 27-35.
13. Ferreira LD, Palmer TN, Fournier PA. Prolonged exposure to halothane and associated changes in carbohydrate metabolism in rat muscles in vivo. J Appl Physiol 1998; 84: 1470-1474.
14. Nawano M, Oku A, Ueta K et al. Hyperglycemia contributes insulin resistance in hepatic and adipose tissue but not skeletal muscle of ZDF rats. Am J Physiol Endocrinol Metab 2000; 278: E535-E543.
15. Sato S, Katayama K, Kakemi M, Koizumi T. A kinetic study of chlorpromazine on the hyperglycemic response in rats. II. Effect of chlorpromazine on plasma glucose. J Pharmacobiodyn 1988; 11: 492-503.
16. Ruiz JO, Simmons RL, Callender CO, Kjellstrand CM, Buselmeier TJ, Najarian JS. Steroid diabetes in renal transplant recipients: pathogenetic factors and prognosis. Surgery 1973; 73: 759-765.
17. Arner P, Gunnarsson R, Blomdahl S, Groth CG. Some characteristics of steroid diabetes: a study in renal-transplant recipients receiving high-dose corticosteroid therapy. Diabetes Care 1983; 6: 23-25.
18. Schulz TB, Jorde R, Burhol PG. Fasting portal vein plasma levels of gastric inhibitory polypeptide (GIP) and extractable fasting GIP in the duodenal wall in rats treated with methylprednisolone or alloxan compared with normal controls. Scand J Gastroenterol 1982; 17: 487-490.
19. Thompson MD, Gallagher WJ, Iaizzo PA, Lanier WL. The effect of chronic dexamethasone-induced hyperglycemia and its acute treatment with insulin on brain glucose and glycogen concentrations in rats. Anesthesiology 2000; 93: 1279-1284.
20. Pellacani A, Fornengo P, Bruno A et al. Acute methylprednisolone administration induces a transient alteration of glucose tolerance and pyruvate dehydrogenase in humans. Eur J Clin Invest 1999; 29: 861-867.
21. Thomas CR, Turner SL, Jefferson WH, Bailey CJ. Prevention of dexamethasone-induced insulin resistance by metformin. Biochem Pharmacol 1998; 56: 1145-1150.
22. Chan L, Means AR, O'Malley BW. Steroid hormone regulation of specific gene expression. Vitam Horm 1978; 36: 259-295.
23. Jin JY, DuBois DC, Almon RR, Jusko WJ. Receptor/gene-mediated pharmacodynamic effects of methylprednisolone on phosphoenolpyruvate carboxykinase regulation in rat liver. J Pharmacol Exp Ther 2004; 309: 328-339.
24. Baxter JD. Glucocorticoid hormone action. Pharmacol Ther [B] 1976; 2: 605-669.
25. Manganiello V, Vaughan M. An effect of dexamethasone on adenosine 3′,5′-monophosphate content and adenosine 3′,5′-monophosphate phosphodiesterase activity of cultured hepatoma cells. J Clin Invest 1972; 51: 2763-2767.
26. Jin JY, Almon RR, DuBois DC, Jusko WJ. Modeling of corticosteroid pharmacogenomics in rat liver using gene microarrays. J Pharmacol Exp Ther 2003; 307: 93-109.
27. Pagano G, Cavallo-Perin P, Cassader M et al. An in vivo and in vitro study of the mechanism of prednisone-induced insulin resistance in healthy subjects. J Clin Invest 1983; 72: 1814-1820.
28. Rossetti L, Giaccari A, DeFronzo RA. Glucose toxicity. Diabetes Care 1990; 13: 610-630.
29. Marshall S, Bacote V, Traxinger RR. Discovery of a metabolic pathway mediating glucose-induced desensitization of the glucose transport system. Role of hexosamine biosynthesis in the induction of insulin resistance. J Biol Chem 1991; 266: 4706-4712.
30. Shulman GI. Cellular mechanisms of insulin resistance in humans. Am J Cardiol 1999; 84: 3J-10J.
31. Yki-Jarvinen H, Makimattila S. Insulin resistance due to hyperglycaemia: an adaptation protecting insulin-sensitive tissues. Diabetologia 1997; 40 (Suppl 2): S141-S144.
32. Berger MP, Rodbard D. A pharmacodynamic approach to optimizing insulin therapy. Comput Methods Programs Biomed 1991; 34: 241-253.
33. Cobelli C, Federspil G, Pacini G, Salvan A, Scandellari C. An integrated mathematical model of the dynamics of blood glucose and its hormonal control. Math Biosci 1982; 58: 27-60.
34. Sturis J, Polonsky KS, Mosekilde E, Van Cauter E. Computer model for mechanisms underlying ultradian oscillations of insulin and glucose. Am J Physiol 1991; 260: E801-E809.
35. Cobelli C, Bier DM, Ferrannini E. Modeling glucose metabolism in man: theory and practice. Horm Metab Res Suppl 1990; 24: 1-10.
36. Dalla Man C, Caumo A, Cobelli C. The oral glucose minimal model: estimation of insulin sensitivity from a meal test. IEEE Trans Biomed Eng 2002; 49: 419-429.
37. Toffolo G, Cobelli C. The hot IVGTT two-compartment minimal model: an improved version. Am J Physiol Endocrinol Metab 2003; 284: E317-E321.
38. Zhang B, Saku K, Arakawa K. Quantification of the effects of troglitazone on insulin sensitivity and beta-cell function in Watanabe heritable hyperlipidemic rabbits: a minimal model analysis. Metabolism 1997; 46: 273-281.
39. Jusko WJ. Receptor-mediated pharmacodynamics of corticosteroids. Prog Clin Biol Res 1994; 387: 261-270.